Comparison

PF-04929113 (SNX-5422)

Item no. V0890-100mg
Manufacturer InvivoChem LLC
CASRN 908115-27-5
Amount 100 mg
Quantity options 10 mg 250 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V0890CAS #:908115-27-5 Purity >=98%

Description: PF-04929113 (SNX-5422; PF04929113; PF-4929113) is a potent and selective inhibitor of heat shock protein 90 (HSP90) with potential antineoplastic activity. It inhibits HSP90 with a Kd of 41 nM. PF 04929113 exhibits excellent in vivo antitumor efficacy in fox chase SCID mice bearing MM.1S cells.

Description:ox chase SCID mice bearing MM.1S cells.

References: J Med Chem. 2009; 52(14):4288-305; Blood. 2009; 113(4):846-55; Clin Cancer Res. 2011; 17(8):2301-13.

References:

Related CAS: 1173111-67-5 (mesylate); 908115-27-5 (free base);

Molecular Weight (MW)
521.53
Formula
C25H30F3N5O4
CAS No.
908115-27-5 (free base);
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: 5 mg/mL (9.6 mM)
Water: < 1 mg/mL
Ethanol: 3 mg/mL (5.2 mM)
Solubility (In vivo)
0.5% CMC+0.25% Tween 80: 25mg/mL
Synonyms
SNX-5422; PF 4929113; PF04929113; PF 04929113; SNX5422; SNX 5422; PF-04929113; PF4929113; PF-4929113;

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Delivery expected until 9/4/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close